Biometrics: Dividend

Showing posts with label Dividend. Show all posts

NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share

BEDFORD, Mass., June 30, 2014 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services, previously announced on June 26, 2014 that its Board of Directors had declared a special cash dividend of $1.75 per share, or approximately $40 million in total. The Board established a record date of July 10, 2014 and a payment date of July 24, 2014. The Company was subsequently notified by NASDAQ that it had set an ex-dividend date for this special cash dividend. An ex-dividend date of July 25, 2014 has been established by NASDAQ.

We encourage shareholders to contact their brokers in order to understand the Nasdaq Rules and Regulations regarding the effect of selling shares of our common stock following the record date on their eligibility to receive the dividend.

About Aware
Aware is a leading provider of biometrics software products and development services to governments, system integrators, and solution providers globally. Our products include SDKs, software components, workstation applications, and a modular, centralized, service-oriented platform. They fulfill a broad range of functions critical to biometric authentication and search, including face, fingerprint, and iris autocapture, image quality assurance, data compliance, capture hardware peripheral abstraction, centralized data processing and workflow, subsystem connectivity, and biometric matching algorithms. The products are used to enable identity-centric security solutions with biometrics for applications including border management, credentialing and access control, intelligence and defense, and law enforcement. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2013 and other reports and filings made with the Securities and Exchange Commission.

Aware is a trademark or registered trademark of Aware, Inc.
Any other trademarks appearing herein are the property of their respective owners.

SOURCE Aware, Inc.

Aware, Inc. Declares Special Cash Dividend of $1.75 Per Share, or Approximately $40 Million in Total

BEDFORD, Mass., June 26, 2014 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services, today announced that its Board of Directors has declared a special cash dividend of $1.75 per share, or approximately $40 million in total. The special cash dividend will be paid on July 24, 2014 to shareholders of record as of July 10, 2014.

The Board of Directors has determined that the company's current cash balances exceed our capital requirements and has decided to return cash to shareholders.

The federal income tax treatment of the special cash dividend will depend on the amount of the company's current and accumulated earnings and profits as of December 31, 2014, as determined by the Internal Revenue Code. We currently estimate that for federal income tax purposes approximately 10% of the special cash dividend will be treated as a dividend and that approximately 90% will be treated as a return of capital and/or capital gain. We will notify shareholders in early 2015 as to the actual amounts of each.

With respect to a share of company stock, (i) the amount treated as a dividend for federal income tax purposes may be treated as qualified dividend income if the shareholder satisfies certain requirements, and (ii) the amount of the special cash dividend that is not treated as a dividend for federal income tax purposes will be treated first as a return of capital to the extent of a shareholder's adjusted tax basis in such share, and then as capital gain. We encourage shareholders to consult their tax advisors to understand how this special cash dividend may affect their tax obligations.

We also encourage shareholders to contact their brokers in order to understand the Nasdaq Rules and Regulations regarding the effect of selling shares of our common stock following the record date on their eligibility to receive the dividend.

See Aware's website for more information about our biometrics software products.

Safe Harbor Warning
Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as the expected tax treatment of the special cash dividend, estimates or projections of future revenue and earnings, and the growth of the biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements.

Risk factors related to our business and any of our forward-looking statements include, but are not limited to: i) our operating results may fluctuate significantly and are difficult to predict; ii) we derive a significant portion of our revenue from government customers, and our business may be adversely affected by changes in the contracting or fiscal policies of those governmental entities; iii) we derive a significant portion of our revenue from third party channel partners; iv) we face intense competition from other biometrics solution providers; v) our business is subject to rapid technological change; vi) our software products may have errors, defects or bugs which could harm our business; vii) our business may be adversely affected by our use of open source software; viii) our intellectual property is subject to limited protection; ix) we may be sued by third parties for alleged infringement of their proprietary rights; x) we must attract and retain key personnel; xi) we rely on single sources of supply for certain components used in our hardware products; xii) our business may be affected by government regulations and adverse economic conditions; xiii) we may make acquisitions that could adversely affect our results; and xiv) the tax treatment of the special cash dividend will depend on our current and accumulated earnings and profits as of December 31, 2014, which we will not know until early 2015.

Aware is a trademark or registered trademark of Aware, Inc.
Any other trademarks appearing herein are the property of their respective owners.

SOURCE Aware, Inc.

Medbox Issues Special Stock Dividend to Shareholders

WEST HOLLYWOOD, Calif., Feb. 3, 2014 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced FINRA consent and issuance of a common stock dividend. The 100% stock dividend issuance will have a record date of December 18th, 2013, and a pay date of February 3rd, 2014.

Management clarified that the class of shares to receive the dividend is the common shares only and not the preferred class of shares held by company executives. The shares are issued on a one-year restricted basis.

"I am extremely elated that we were able to give back to our shareholders in this way," stated Vincent Mehdizadeh, COO at Medbox, Inc. "Being a leader means setting a good example for other companies in the medical marijuana industry to follow. As we transition to becoming an SEC filer in mid-March, its important that we now focus on strengthening our management team, which is our next key priority."

About Medbox, Inc:

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Florida, and has their corporate headquarters in West Hollywood, California.

Medbox offers their patented systems, software and consulting services to pharmacies, dispensaries and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets (Pink Sheets), ticker symbol MDBX.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

For more information on Medbox, please contact us at (800) 762-1452 or go online to www.medboxinc.com.

Contacts:
Investors
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@HaydenIR.com

SOURCE Medbox, Inc.

Landauer, Inc. Declares Regular Cash Dividend

GLENWOOD, Ill., Dec. 3, 2013 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, announced today that its Board of Directors declared, at its meeting on December 3, 2013, a regular quarterly cash dividend of $0.55 per share for the first quarter of fiscal 2014. The dividend will be paid on January 6, 2014, to shareholders of record on December 23, 2013.

About Landauer

Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure, the leading domestic provider of outsourced medical physics services, as well as a provider of high quality medical accessories used in radiology, radiation therapy, and image guided surgery procedures. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.8 million individuals globally. In addition, through its Medical Physics segment, the Company provides therapeutic and imaging physics services to the medical physics community. Through its Medical Products segment, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures. For information about Landauer, please visit our website at http://www.landauer.com.

For the latest news releases and other corporate documents on Landauer, Inc., visit www.landauer.com

SOURCE Landauer, Inc.

RELATED LINKS
http://www.landauerinc.com

reade more...

Pages

.

NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share

Aware, Inc. Declares Special Cash Dividend of $1.75 Per Share, or Approximately $40 Million in Total

Medbox Issues Special Stock Dividend to Shareholders

Landauer, Inc. Declares Regular Cash Dividend